Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian L Harris

Showing results (321-330 of 443) with videos related to

Pageof 45
Sort By:
Nuclear Medicine and Biology|May 7, 2016
Labeling and preliminary in vivo assessment of niobium-labeled radioactive species: A proof-of-concept studyValery Radchenko, Penelope Bouziotis, Theodoros Tsotakos, et al.
Cancer|February 27, 2010
hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancerHarriet E Gee, Carme Camps, Francesca M Buffa, et al.
European Journal of Cancer (Oxford, England : 1990)|January 29, 2013
An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3Anassuya Ramachandran, Guy Betts, Sara Bhana, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 19, 2013
Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trialAmanda Eustace, Joely J Irlam, Janet Taylor, et al.
Breast Cancer Research : BCR|February 5, 2011
The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifenStephen B Fox, Daniele Generali, Alfredo Berruti, et al.
Blood|June 19, 2010
New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomesHelen Sheldon, Emily Heikamp, Helen Turley, et al.
Breast Cancer Research : BCR|April 28, 2011
Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancersMax Yan, Nicholas Jene, David Byrne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Hypoxia-inducible factor 1alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervixGillian J Hutchison, Helen R Valentine, Juliette A Loncaster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2012
Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapyAlan McIntyre, Shalini Patiar, Simon Wigfield, et al.
Molecular and Cellular Biology|June 21, 2005
Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinomaRaju R Raval, Kah Weng Lau, Maxine G B Tran, et al.
Pageof 45

Showing results (321-330 of 443) with videos related to

Sort By:
Pageof 45
Nuclear Medicine and Biology|May 7, 2016
Labeling and preliminary in vivo assessment of niobium-labeled radioactive species: A proof-of-concept studyValery Radchenko, Penelope Bouziotis, Theodoros Tsotakos, et al.
Cancer|February 27, 2010
hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancerHarriet E Gee, Carme Camps, Francesca M Buffa, et al.
European Journal of Cancer (Oxford, England : 1990)|January 29, 2013
An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3Anassuya Ramachandran, Guy Betts, Sara Bhana, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 19, 2013
Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trialAmanda Eustace, Joely J Irlam, Janet Taylor, et al.
Breast Cancer Research : BCR|February 5, 2011
The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifenStephen B Fox, Daniele Generali, Alfredo Berruti, et al.
Blood|June 19, 2010
New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomesHelen Sheldon, Emily Heikamp, Helen Turley, et al.
Breast Cancer Research : BCR|April 28, 2011
Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancersMax Yan, Nicholas Jene, David Byrne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Hypoxia-inducible factor 1alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervixGillian J Hutchison, Helen R Valentine, Juliette A Loncaster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2012
Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapyAlan McIntyre, Shalini Patiar, Simon Wigfield, et al.
Molecular and Cellular Biology|June 21, 2005
Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinomaRaju R Raval, Kah Weng Lau, Maxine G B Tran, et al.
Pageof 45